Motilal Oswal's research report on Coromandel International
CRIN (Coromandel International) reported 7% YoY EBIT growth, led by a strong EBIT growth of 26% in the Crop protection segment (EBIT contribution 21%), while the Nutrients and Other Allied segment (EBIT contribution 79%) registered a growth of only 4% YoY. We maintain our earnings estimates for FY24/FY25 and reiterate our BUY rating on the stock.
Outlook
We maintain our earnings estimates for FY24/FY25 and value the stock at 16x FY25 EPS to arrive at our TP of INR1,180. We reiterate our BUY rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
